GHK-Cu, or Glycyl-L-Histidyl-L-Lysine Copper, is a naturally occurring copper-binding tripeptide found in human biological fluids. Discovered in 1973 by Dr. Loren Pickart, GHK-Cu has been extensively researched for its remarkable regenerative and protective properties throughout the body. Its levels naturally decline with age, sparking significant interest in its potential as an anti-aging and healing agent.
GHK-Cu functions by forming a stable complex with copper ions (Cu²²?), which enhances coppers bioavailability and its ability to influence various biological pathways. Its mechanisms of action are multifaceted:
Delivering peptides like GHK-Cu via sublingual oral dissolvable strips (ODTs) addresses the limitations of traditional administration methods. Oral capsules face degradation in the harsh stomach environment, reducing effectiveness. Injections, while effective, are inconvenient and uncomfortable for regular use.
ODTs offer an innovative solution: placed under the tongue, these thin films rapidly dissolve, allowing GHK-Cu to be absorbed directly into the bloodstream through the highly vascularized oral mucosa. This bypasses first-pass metabolism in the liver and avoids degradation in the gastrointestinal tract, potentially leading to faster action and improved bioavailability. This method significantly enhances convenience for daily use.
Based on numerous preclinical studies and some human trials, GHK-Cu offers a broad range of potential benefits:
While research is promising and GHK-Cu has a long safety record in cosmetic use, its generally not approved by major regulatory bodies like the FDA for medical treatment. More extensive large-scale human clinical trials are necessary to fully establish its long-term efficacy and safety for systemic effects via sublingual ODTs. Despite this, its multifaceted regenerative properties make sublingual GHK-Cu an exciting area in wellness and anti-aging therapies.